
Correlation between left ventricular diastolic function and plasma natriuretic peptide level in children with pulmonary artery hypertension secondary to congenital heart disease
CUI Hua, HU Yi-Xin, FENG Zhi-Chun
Chinese Journal of Contemporary Pediatrics ›› 2010, Vol. 12 ›› Issue (1) : 13-16.
Correlation between left ventricular diastolic function and plasma natriuretic peptide level in children with pulmonary artery hypertension secondary to congenital heart disease
Congenital heart disease / Pulmonary artery hypertension / Left ventricular function / Natriuretic peptide / Child
[1]Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure[J]. Endocr Rev, 2003, 24(5):341-356.
[2]Stephen B, Dalal P, Berger M, Schweitzer P, Hecht S. Noninvasive estimation of pulmonary artery diastolic pressure in patients with tricuspid regurgitation by Doppler echocardiography[J]. Chest, 1999, 116(1):73-77.
[3]Currie PJ, Seuard JB, Chan KJ, Coplu L, Diaz S. Continuous wave Doppler determination of right ventricular pressure a simultaneous Doppler catheterization study in 127 patients[J]. J Am Coll Cardiol, 1985, 6(4):750-756.
[4]刘凤英,梁红,徐兆峰.新生儿持续性肺动脉高压的超声心动图诊断价值[J].中国危重病急救医学,2005,17(7):437.
[5]Jessup M, Sutton MS, Weber KT, Janicki JS.The effect of chronic pulmonary hypertension on left ventricular size,function and interventricular septal motion[J]. Am Heart J, 1987, 113(5):1114-1122.
[6]蔡志雄,蓝斌,陈平,亢卫华,朱稚丹,郭舜奇,等.先天性心脏病合并肺动脉高压患儿心导管与连续波多普勒法测定对比分析[J]. 广东医学, 2006, 27(1):73-75.
[7]郑兆通,张薇,张运.肺动脉高压对左心室功能影响的超声研究[J].中国超声医学杂志, 2005, 21(2):119-123.
[8]Ozer N, Tokgozoglu L, Coplu L, Kes S. Echocardiographic evaluation of left and right ventricular diastolic function in patients with chronic obstructive pulmonary disease[J]. J Am Soc Echocardiogr, 2001, 14(6):557-561.
[9]Mahmud E, Raisinghani A, Hassankhani A, Sadeghi HM, Strachan GM, Auger W, et al. Correlation of left ventricular diastolic filling characteristics with right ventricular overload and pulmonary artery pressure in chronic thromboembolic pulmonary hypertension[J]. J Am Coll Cardiol, 2002, 40(2):318-324.
[10]Munagala VK, Burnett JC Jr, Redfield MM. The natriuretic peptides in cardiovascular medicine[J]. Curr Probl Cardiol, 2004, 29(12):707-769.
[11]Betti I, Castelli G, Barchielli A, Beligni C, Boscherini V, De Luca L, et al. The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study[J]. J Card Fail, 2009, 15(5):377-384.
[12]Favilli S, Frenos S, Lasagni D, Frenos F, Pollini I, Bernini G, et al. The use of B-type natriuretic peptide in paediatric patients: a review of literature[J]. J Cardiovasc Med (Hagerstown), 2009, 10(4):298-302.
[13]Cantinotti M, Vittorini S, Storti S, Prontera C, Murzi M, De Lucia V, et al. Diagnostic accuracy and clinical relevance of brain natriuretic peptide assay in pediatric patients with congenital heart diseases[J]. J Cardiovasc Med (Hagerstown), 2009, 13(1):56-63.
[14]Bernus A, Wagner BD, Accurso F, Doran A, Kaess H, Ivy DD. Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertension[J]. Chest, 2009, 135(3):745-751.
[15]Leuchte HH, Holzapfel M, Baumgartner RA, Neurohr C, Vogeser M, Behr J.Characterization of brain natriuretic peptide in long-term followup of pulmonary arterial hypertension[J]. Chest, 2005, 128(4):2368-2374.
[16]Koch A, Zink S, Singer H. B-type natriuretic peptide in paediatric patients with congenital heart disease[J]. Eur Heart J, 2006, 27(7):861-866.